Florent Morio

Well done !

Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology Since fungal identification methods based on examination of morphological and phenotypic features are complicated by the astonishing diversity of organisms capable of causing human infections especial...

Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology journals.asm.org/doi/10.1128/...

Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1

Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1

Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? | Antimicrobial Agents and Chemotherapy Candidemia remains a prevalent and life-threatening infection, leading to considerable morbidity and mortality, particularly in critically ill patients (1, 2). Invasive candidiasis affects over 250,00...

Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?
Roya Vahedi-Shahandashti, et al.
Antimicrobial Agents and Chemotherapy, 2025
doi.org/10.1128/aac....

Well done Norman !

Myco-Ed: Mycological curriculum for education and discovery Fungi are important and hyperdiverse organisms, yet chronically understudied. Most fungal clades have no reference genomes, impeding our understanding of their ecosystem functions and use as solutions...

Checkout this article I found at PLOS: dx.plos.org/10.1371/jour...

Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1

Not fair...

Excited to share that our story on S. aureus antagonism by Malassezia is live today in Current Biology! The paper has changed a lot since the preprint with the very exciting addition of having identified the antimicrobial effector generated by M. sympodialis.

authors.elsevier.com/c/1kwzj3QW8S...

ECMM Candida IV Study is still open for participation

Global study on non-albicans candidemia

Requirements:

🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available

@martinhoenigl.bsky.social

Antifungal Resistance in Non-fumigatus Aspergillus Species - PubMed This review provides an in-depth exploration of antifungal resistance in non-fumigatus Aspergillus species, mainly focusing on acquired resistance. The available data have been compiled and sometimes ...

🆕️All you need to know about antifungal resistance in non fumigatus Aspergillus species. Great article led by Elie Djenontin and Eric Dannaoui. Glad to contribute 🙏
Just published in Mycoses
pubmed.ncbi.nlm.nih.gov/40219727/

WHO issues its first-ever reports on tests and treatments for fungal infections WHO's reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, shows urgent need for innovative research and development (R&D) to close the gaps. Fungal dis...

WHO reports on the critical lack of medicines and diagnostic tools for invasive fungal diseases.
#PublicHealth

www.who.int/news/item/01...

WHO Issues First Reports on Diagnostics, Therapies For Fungal Infections The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections.

The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections. #IDsky #Medsky

👉Participate in the ECMM Candida IV Study

🌍wide study on candidemia caused by non-albicans Candida

Requirement: clinical data & isolate (not req for C.auris)
Observation period: 04/2024 - 09/2025 Interested?

Email stella.wolfgruber@medunigraz.at

Two journals tried paying peer reviewers and found increased acceptance, earlier reports, and no change in quality.

WHAT A SURPRISE!

Best Papers of AAC, 2024 - Editors in Conversation AAC Edition YouTube video by American Society for Microbiology

Thrilled to see our work featured on @ASMicrobiology's podcast, Best Papers of AAC 2024! 🎉🔬 Thanks to #AAC for the spotlight!
🎧 Listen to the podcast:
www.youtube.com/watch?v=gh0D...
📄 Read the paper: journals.asm.org/doi/10.1128/...

#UR1155 #NantesUniversité

South African brown locusts, Locustana pardalina, hosts fluconazole resistant Candidozyma (Candida) auris (Clade III) The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma ( Candida ) auris is a subject of speculation, with hypotheses including a...

Very interesting! Azole resistant #Candida auris in locusts. www.biorxiv.org/content/10.1...

Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK - PubMed Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK

🚨 One more outbreak of FLC-R Candida parapsilosis described in the UK. @bramspr.bsky.social
pubmed.ncbi.nlm.nih.gov/39878027/

Health researchers alarmed as Trump administration pauses travel, communications The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher.

Health researchers alarmed as Trump admin pauses travel, communications

“Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.”

Gift access: wapo.st/4jI1Wuj

Travel, grant and funding cuts ‘stifling’ US health agencies in new Trump era Halts to external communications, publishing reports and reviewing and approving research a ‘dramatic shift’

BREAKING: US health agency employees are now banned from nearly all travel and certain agencies and programs have been ordered to stop issuing new contracts and grants until further notice. www.theguardian.com/us-news/2025...

US FDA drops web pages on improving clinical trial diversity The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and inclusion efforts at U.S. health agencies.

One of my friends has a grant from the #FDA to look at disparities in clinical trial research and just submitted a manuscript with the findings. She was told today by the collaborators from the #FDA to rescind it.

#Censorhip has started, we are living in authoritarian government.

South African brown locusts, Locustana pardalina, hosts fluconazole resistant Candidozyma (Candida) auris (Clade III) The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma ( Candida ) auris is a subject of speculation, with hypotheses including a...

www.biorxiv.org/content/10.1...

Visual abstract

Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022)

academic.oup.com/cid/advance-...

Enjoying presenting our work on European populations of the lager yeast parent Saccharomyces eubayanus in Coquimbo, Chile SOMICH. Thanks to @fcocubillosr.bsky.social

Early deadline for ECFG17 fast approaching! Come to Dublin in Spring 2025.

EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen on FindAPhD.com PhD Project - EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen , listed on FindAPhD.com

There is competitive #PhD funding for 4 years (eligibility criteria apply) to do a project on the human pathogen Candidozyma (Candida) auris dissecting the genetic basis of its antimicrobial resistance #AMR www.findaphd.com/phds/project... - pls repost

There's still time to apply for this postdoc position in our lab. Ideally suited to someone wanting to develop some independent research, we have lots of new projects to select from! #immunosky 🧪

🦠 Threats from the #Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.

📝 @tonigabaldon.bsky.social, @gabaldonlab.bsky.social

📔 #Microbiology and #MolecularBiology Reviews

📌https://doi.org/10.1128/mmbr.00029-23

#IRBScience

🧪